Showing results (151-160 of 439) with videos related to

Sort By:
Pageof 44
Annals of Hematology|March 7, 2015
An increase in hemoglobin, platelets and white blood cells levels by iron chelation as single treatment in multitransfused patients with myelodysplastic syndromes: clinical evidences and possible biological mechanismsMassimo Breccia, Maria Teresa Voso, Maria Antonietta Aloe Spiriti, et al.
Cancer Chemotherapy and Pharmacology|January 22, 2009
Sequential development of mutant clones in an imatinib resistant chronic myeloid leukaemia patient following sequential treatment with multiple tyrosine kinase inhibitors: an emerging problem?Massimo Breccia, Anna Maria Frustaci, Laura Cannella, et al.
British Journal of Haematology|July 29, 2022
Management of chronic myeloid leukaemia patients treated with ponatinib in a real-life setting: A retrospective analysis from the monitoring registries of the Italian Medicines Agency (AIFA)Massimo Breccia, Pier Paolo Olimpieri, Simone Celant, et al.
Leukemia Research|October 26, 2010
Erythroid response and decrease of WT1 expression after proteasome inhibition by bortezomib in myelodysplastic syndromesGiuliana Alimena, Massimo Breccia, Pellegrino Musto, et al.
Critical Reviews in Oncology/Hematology|November 27, 2020
Digital droplet PCR as a predictive tool for successful discontinuation outcome in chronic myeloid leukemia: Is it time to introduce it in the clinical practice?Gioia Colafigli, Emilia Scalzulli, Alessio Di Prima, et al.
BMJ Supportive & Palliative Care|May 9, 2024
Financial toxicity and health-related quality of life in long-term survivors of acute promyelocytic leukaemiaFrancesco Sparano, Maria Teresa Voso, Adriano Venditti, et al.
Cancer|August 1, 2006
Sudden blast crisis in patients with Philadelphia chromosome-positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapyGiuliana Alimena, Massimo Breccia, Roberto Latagliata, et al.
Mediterranean Journal of Hematology and Infectious Diseases|June 30, 2011
Low incidence rate of opportunistic and viral infections during imatinib treatment in chronic myeloid leukemia patients in early and late chronic phaseMassimo Breccia, Corrado Girmenia, Roberto Latagliata, et al.
Frontiers in Oncology|May 17, 2023
Case Report: Infectious prophylaxis in hematological malignanciesMauro Passucci, Chiara Masucci, Francesca Paoletti, et al.
Leukemia Research|December 4, 2013
Aberrant phenotypic expression of CD15 and CD56 identifies poor prognostic acute promyelocytic leukemia patientsMassimo Breccia, Maria Stefania De Propris, Clara Minotti, et al.
Pageof 44